Clinical Trials Directory

Trials / Conditions / Follicular Lymphoma Grade 3B

Follicular Lymphoma Grade 3B

13 registered clinical trials studyying Follicular Lymphoma Grade 3B — 7 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingGeriatric-guided Care Versus Conventional Care in Elderly Unfit/Frail Patients With Diffuse Large B-cell Lymph
NCT07476105
Fondazione Italiana Linfomi - ETSN/A
RecruitingClinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma
NCT06830031
Shanghai Exuma Biotechnology Ltd.Phase 1
RecruitingSynKIR-310 for Relapsed/Refractory B-NHL
NCT06544265
Verismo TherapeuticsPhase 1
RecruitingP-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies
NCT06014762
Poseida Therapeutics, Inc.Phase 1
Active Not RecruitingRelmacabtagene Autoleucel As Second-Line Therapy in Adult Patients with Aggressive B-cell NHL
NCT06093841
Shanghai Ming Ju Biotechnology Co., Ltd.Phase 2
Active Not RecruitingMosunetuzumab in Combination With Platinum-Based Salvage Chemotherapy in Patients With Relapsed/Refractory Agg
NCT05464329
Washington University School of MedicinePhase 1
RecruitingLong-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy
NCT05377307
Pell Bio-Med Technology Co., Ltd.—
RecruitingPhase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell
NCT05326243
Pell Bio-Med Technology Co., Ltd.Phase 1 / Phase 2
RecruitingR-CDOP Regimen in the Treatment of Newly Diagnosed Non-Hodgkin's Lymphoma With High Tumor Burden
NCT05040555
oubai, MD/PhDN/A
CompletedAutologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies
NCT04088890
Matthew FrankPhase 1
TerminatedDenintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymp
NCT02855359
Seagen Inc.Phase 2
TerminatedTreatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lym
NCT02592876
Seagen Inc.Phase 2
UnknownR-CEOP-90/R-CEOP-70 Versus R-CHOP-50 in the Treatment of Diffuse Large B-cell Lymphoma and Follicular Lymphoma
NCT01852435
Ruijin HospitalPhase 3